Literature DB >> 12821587

Drug-eluting stents: costs versus clinical benefit.

William W O'Neill1, Martin B Leon.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12821587     DOI: 10.1161/01.CIR.0000079018.84618.0E

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  9 in total

Review 1.  New approaches to preventing restenosis.

Authors:  Balram Bhargava; Ganesan Karthikeyan; Alexandre S Abizaid; Roxana Mehran
Journal:  BMJ       Date:  2003-08-02

Review 2.  Analysis of prosthetic cardiac devices: a guide for the practising pathologist.

Authors:  J Butany; M J Collins
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

3.  Clinical outcomes with Biolimus (A9)™ eluting stent, 'BioMatrix' in diabetic patients--interim results from multicenter post market surveillance registry in India.

Authors:  Ashok Seth; Shirish Hiremath; Sameer Dani; Sunil Kapoor; R K Jain; Rajpal Abhaichand; Shailendra Trivedi; Upendra Kaul; Aruna Patil; Bhushan Khemnar; Hrishikesh Rangnekar
Journal:  Indian Heart J       Date:  2013-09-21

4.  Systemic inflammation after drug-eluting stent placement.

Authors:  Prospero B Gogo; David J Schneider; Matthew W Watkins; Edward F Terrien; Burton E Sobel; Harold L Dauerman
Journal:  J Thromb Thrombolysis       Date:  2005-04       Impact factor: 2.300

Review 5.  [When are drug-eluting stents effective? A critical analysis of the presently available data].

Authors:  S Silber
Journal:  Z Kardiol       Date:  2004-09

6.  Combining short stent implantation and drug-eluting stenting for routine use yields a low restenosis rate.

Authors:  Ulrich Dietz; Cheryl Dauer; Heinz Lambertz
Journal:  Exp Clin Cardiol       Date:  2006

7.  Combining short stent implantation and drug-eluting stenting for routine use yields a low restenosis rate.

Authors:  Ulrich Dietz; Cheryl Dauer; Heinz Lambertz
Journal:  Curr Control Trials Cardiovasc Med       Date:  2005-12-13

8.  Issues in the acquisition, development, and use of technology in health care.

Authors:  Raymond J Lanzafame
Journal:  JSLS       Date:  2006 Oct-Dec       Impact factor: 2.172

9.  Anti-inflammatory effect of abciximab-coated stent in a porcine coronary restenosis model.

Authors:  Young Joon Hong; Myung Ho Jeong; Sang Rok Lee; Seo Na Hong; Kye Hun Kim; Hyung Wook Park; Ju Han Kim; Weon Kim; Youngkeun Ahn; Jeong Gwan Cho; Jong Chun Park; Jung Chaee Kang
Journal:  J Korean Med Sci       Date:  2007-10       Impact factor: 2.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.